Uger Robert 4
4 · Trillium Therapeutics Inc. · Filed May 11, 2021
Insider Transaction Report
Form 4
Uger Robert
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Shares
2021-05-07$0.31/sh+3,646$1,141→ 3,646 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-05-07−3,646→ 109,375 totalExercise: $0.31Exp: 2029-11-07→ Common Shares (3,646 underlying) - Sale
Common Shares
2021-05-07$9.30/sh−3,646$33,908→ 0 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The exercise price of these options is $0.38 CAD and has been translated to USD in the table above at an exchange rate of $1.00 CAD to $0.8237 USD.
- [F3]25% of the options vest on the one year anniversary of the grant date and the remaining options vest in equal monthly installments over the following 36 months.